Navigation Links
Hemochromatosis Patients' Blood is Safe

Blood donors with hemochromatosis, a disorder in which iron accumulates in organs and body tissues, do not pose a greater risk to blood safety than other donors, according to the results of a study funded by the National Heart, Lung, and Blood Institute (NHLBI). //

Hemochromatosis patients are treated with periodic phlebotomies or "blood letting" to remove excess iron from their body. Because these patients benefit medically and financially by giving blood, there has been concern that they might donate despite having infectious disease risk factors and that their blood might be less safe. As a result, FDA regulations have not promoted blood donation from hemochromatosis patients.

"Hemochromatosis patients had no more risk of transmitting viral infections than did other donors. This finding should help guide future decisions on blood donations by these patients. If people with hemochromatosis qualify as donors then that could potentially have a significant impact on the national blood supply," said NHLBI Director Dr. Claude Lenfant. Current FDA regulations for blood donation do not prohibit blood from hemochromatosis patients.


'"/>




Page: 1

Related medicine news :

1. Colon cancer risk linked to genes causing Hemochromatosis
2. Painkillers Do Not Shorten Dying Patients Lives
3. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
4. Doctors Response To Patients Religious Beliefs Can Vary
5. Queensland Health Holding Back Dental Patients HIV Results
6. New Genetic Test Predicts Eye-Cancer Patients Futures
7. Patients Requests for Antidepressants can Influence Physician Evaluation of Depression
8. Recommendations for Treatment of Blood Pressue
9. Blood Cells Capable of Regenerating Liver
10. Blood clots likely in long travel
11. Blood transfusions beneficial after heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... ... August 03, 2020 , ... Actuate Therapeutics, Inc. (Actuate), ... first-line advanced pancreatic cancer in a phase 2 study of 9-ING-41, as a ... 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase kinase-3 beta (GSK-3ß) inhibitor ...
(Date:7/31/2020)... ... 2020 , ... National Association of Chain Drug Stores (NACDS) ... nation’s ongoing preparations for the eventual deployment of COVID-19 vaccines: , “By any ... essential component of vaccine deployment. They will need to be part of the ...
(Date:7/22/2020)... ... 2020 , ... Ocean Tomo Transactions, LLC will auction a ... from Brock University for jurisdictions throughout North America, Europe and Asia. Ocean ... the manufacturing processes of novel opioid related compositions for pain management as well ...
(Date:7/18/2020)... , ... July 17, 2020 , ... ... Honorable Mention in the Hermes Creative Awards, was a charitable push put together ... positivity to contrast the news during the pandemic, HMI asked individuals in its ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... ... abundant life, Isagenix International is evolving its brand. While the global ... more holistic approach that supports physical, emotional, and spiritual wellbeing. The company announced ...
Breaking Medicine News(10 mins):
(Date:7/22/2020)... , ... July 22, 2020 , ... ... technology, is proud to announce the addition of Moderna to its growing customer ... rely on its technology for trial disclosure management, patient engagement and study recruitment. ...
(Date:7/18/2020)... ... July 17, 2020 , ... A Perspective essay ... illustrate how implicit bias among psychiatrists and other clinicians can affect patient-clinician communication ... people. The Perspective was authored by researchers at The Fenway Institute and Massachusetts ...
(Date:7/10/2020)... ... ... The team at The Keyhole Heart Clinic have been hard at ... a multitude of user enhancements and streamlined navigation for a more intuitive user experience. ... which will allow patients to find the information they need quickly. Of particular interest ...
Breaking Medicine Technology: